A doctor has revealed six of the biggest mistakes people on weight loss drugs can make. Nobody's perfect, but when it comes ...

Another consequence of the rise increase is for those who are not prescribed the medication but who wish to acquire it ...

Teva Pharmaceuticals gained FDA approval to launch the first generic GLP-1 drug for weight loss, a liraglutide injection based on Saxenda.

More than 1.1 million prescriptions for the weight-loss drugs Saxenda and Wegovy have been issued in South Korea over the ...

Israeli drugmaker Teva Pharmaceutical Industries has announced US Food and Drug Administration (FDA) approval and launch of a ...

Teva Pharmaceuticals has launched the first generic GLP-1 drug for weight loss in adults and adolescents; a lower-cost ...

Teva Pharmaceuticals announced in late August 2025 that it received FDA approval and commenced the U.S. launch of its generic version of Saxenda® (liraglutide injection), which had annual sales of ...

Parsippany: Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., has announced the FDA approval and U.S. launch of a generic version of Saxenda ...

The drug, which is prescribed to around 90% of people in the UK using weight-loss injections, will see the cost of its ...

The Ahmed Group has launched AG Property Trust (“AGPT”), a private real estate investment trust (REIT) now open to accredited investors.

Teva is releasing a generic version of Novo Nordisk’s Saxenda, a liraglutide injection. Liraglutide injection is indicated for adults with obesity or overweight who also have weight related medical ...

Investing.com -- Teva Pharmaceutical Industries Ltd ADR (NYSE:TEVA) stock rose 2.7% after the company announced FDA approval and U.S. launch of its generic version of Saxenda (liraglutide injection), ...